Mallik Ameet Insider Trades

Insider Trading History

Track insider trading activity for Mallik Ameet. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $4.77M 1,550,000 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.59M 900,000 shares
$3.99
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $4.46M 1,446,769 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$412k 103,231 shares
$3.99
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $4.06M 1,319,101 shares
Last Trade
Dec 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$767k 233,146 shares
$3.29
$3.08
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director
Holding Value $163k 16,928 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.4k 7,828 shares
$9.12
$9.63
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $4.78M 1,552,247 shares
Last Trade
May 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$34.5k 26,758 shares
$1.29
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $4.86M 1,579,005 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 650,000 shares
$1.61
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $2.86M 929,005 shares
Last Trade
Dec 06, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$746k 238,343 shares
$3.13
$3.08
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $3.6M 1,167,348 shares
Last Trade
May 07, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$133k 29,731 shares
$4.48
$3.08
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director
Holding Value $2.19M 227,500 shares
Last Trade
Mar 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6M 150,000 shares
$17.35
$9.63
Adc Therapeutics SA
Adc Therapeutics SA ADCT
Chief Executive Officer
Holding Value $3.69M 1,197,079 shares
Last Trade
Jan 02, 2024 Sale
$2.86M 1,692,961 shares
$1.69
$3.08
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director
Holding Value $766k 79,500 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.04M 79,500 shares
$38.25
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director
Holding Value $303k 31,500 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.79M 31,500 shares
$183.75
$9.63
Rafael Holdings
Rafael Holdings RFL
Director
Holding Value $0 0 shares
Last Trade
Feb 01, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.77M 908,497 shares
$4.15
$1.35
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director
Holding Value $530k 55,000 shares
Last Trade
Aug 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.2M 55,000 shares
$312.25
$9.63
Rafael Holdings
Rafael Holdings RFL
CHIEF EXECUTIVE OFFICER
Holding Value $1.23M 908,497 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.6M 908,497 shares
$44.70
$1.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up